EDUARDO
FERNÁNDEZ-CRUZ PÉREZ
Investigador hasta 2016
Hospital Clínico San Carlos de Madrid
Madrid, EspañaPublicaciones en colaboración con investigadores/as de Hospital Clínico San Carlos de Madrid (7)
2018
-
Increased indoleamine-2,3-dioxygenase activity is associated with poor clinical outcome in adults hospitalized with influenza in the INSIGHT FLU003Plus study
Open Forum Infectious Diseases, Vol. 5, Núm. 1
2014
-
Experience in IVIg therapy for selected women with recurrent reproductive failure and NK cell expansion
American Journal of Reproductive Immunology, Vol. 71, Núm. 5, pp. 458-466
2013
-
High prevalence of allergy-like respiratory diseases in common variable immunodeficiency
Journal of Investigational Allergology and Clinical Immunology
-
Sequential combined therapy with Omalizumab and Rituximab: A new approach to severe atopic dermatitis
Journal of Investigational Allergology and Clinical Immunology, Vol. 23, Núm. 3, pp. 190-196
2010
-
IFNβ-1a therapy for multiple sclerosis expands regulatory CD8+ T cells and decreases memory CD8+ subset: A longitudinal 1-year study
Clinical Immunology, Vol. 134, Núm. 2, pp. 148-157
2009
-
Clinical response to interferon-β-1a may be linked to low baseline circulating BDCA1 myeloid dendritic cells. Differential role of circulating dendritic cells and CD4+ regulatory T-cells in relapsing-remitting multiple sclerosis: A 1-year longitudinal study
Journal of Neuroimmunology, Vol. 212, Núm. 1-2, pp. 112-120
2007
-
Interferon beta-1a therapy enhances CD4+ regulatory T-cell function: An ex vivo and in vitro longitudinal study in relapsing-remitting multiple sclerosis
Journal of Neuroimmunology, Vol. 182, Núm. 1-2, pp. 204-211